Literature DB >> 12702931

Intratumoral versus intraparenchymal injection technique for lymphoscintigraphy in breast cancer.

Susanne H Estourgie1, Omgo E Nieweg, Renato A Valdés Olmos, Emiel J Th Rutgers, Bin B R Kroon.   

Abstract

A 1.5-cm nonpalpable mass was detected in the upper outer quadrant of the left breast by screening mammography in a 55-year-old woman. The patient was scheduled for a sentinel node procedure, and lymphoscintigraphy was performed the day before surgery. Unintentionally, she received an intraparenchymal tracer injection 3 cm away from the malignant lesion instead of the intended intratumoral injection. Lymphoscintigraphy revealed two sentinel nodes in the axilla. A second dose of Tc-99m nanocolloid was injected the next day into the primary tumor through a catheter that had been inserted under ultrasound guidance the previous day. Once more, a lymphoscintigraphic image was obtained that showed additional sentinel nodes in two different regions outside the axilla. This observation supports the authors' contention that lymphatic watersheds exist in the breast and highlights the importance of tracer administration into or close to the tumor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702931     DOI: 10.1097/01.RLU.0000063409.68758.D4

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution.

Authors:  Brian A Hrycushko; Shihong Li; Beth Goins; Randal A Otto; Ande Bao
Journal:  Med Phys       Date:  2011-03       Impact factor: 4.071

2.  The impact of drainage pathways on the detection of nodal metastases in prostate cancer: a phase II randomized comparison of intratumoral vs intraprostatic tracer injection for sentinel node detection.

Authors:  Esther M K Wit; Florian van Beurden; Gijs H Kleinjan; Nikolaos Grivas; Clarize M de Korne; Tessa Buckle; Maarten L Donswijk; Elise M Bekers; Fijs W B van Leeuwen; Henk G van der Poel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-11-08       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.